More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

2019 Half Year Investor Presentation

Feb 21, 2019 at 9:58 PM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Feb 21, 2019 at 9:58 PM EST · 35 pages · English

On 6ix: 6ix.com/news/2019-half-year-investor-presentation

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

In the deck

  • Mayne Pharma Group — Investor Presentation (February 2019)35 slidesFeb 22, 2019

Story so far

  • 2019 Half Year Media ReleaseFeb 21, 2019
  • Half Year AccountsFeb 21, 2019
  • 2018 Full Year Results Investor PresentationAug 24, 2018

Earlier from Mayne Pharma

  • 2019 Half Year Media ReleaseFeb 21, 2019
  • Half Year AccountsFeb 21, 2019
  • Tolsura (SUBA-itraconazole) capsule now launched in the USJan 29, 2019
  • FDA approval of Tolsura (SUBA-itraconazole) capsulesDec 11, 2018
  • 2018 AGM CEOs SpeechNov 28, 2018

Later from Mayne Pharma

  • 2019 Full Year Results Media ReleaseAug 22, 2019
  • 2019 Full Year Results Investor PresentationAug 22, 2019
  • MYX signs license agreement for novel oral contraceptiveOct 1, 2019
  • E4/DRSP contraceptive presented at EU gynecology conferenceOct 22, 2019
  • 2019 AGM CEOs SpeechNov 21, 2019
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer